Lipopolysaccharide-induced inflammatory cytokine production by Schwann's cells dependent upon TLR4 expression

Journal of Neuroimmunology

Volumn 212, Issue 1-2, 2009, Pages 26-34

  Hao, Hsiao Nan ^a   Peduzzi Nelson, Jean D ^b   VandeVord, Pamela J ^c   Barami, Kaveh ^d   DeSilva, Stephen P ^a   Pelinkovic, Dalip ^a   Morawa, Lawrence G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Wayne State University   (United States)

^d Memorial Hospital Jacksonville   (United States)

Author keywords

Autoimmune neuritis; Cytokine; LPS; Schwann's cell; TLRs

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GANGLIOSIDE GM1 ANTIBODY; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; GENE REPRESSION; IN VITRO STUDY; IN VIVO STUDY; NEURITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHWANN CELL; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CELLS, CULTURED; CYTOKINES; FEMALE; LIPOPOLYSACCHARIDES; MYELOID DIFFERENTIATION FACTOR 88; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCHWANN CELLS; TOLL-LIKE RECEPTOR 4;

EID: 67649884545     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.04.020     Document Type: Article

References (58)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 780-785
2. Apte R.N., Ascher O., and Pluznik D.H. Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide. J. Immunol. 119 (1977) 1898-1902
3. Ang C.W., Laman J.D., Willison H.J., Wagner E.R., Endtz H.P., De Klerk M.A., Tio-Gillen A.P., Van den Braak N., Jacobs B.C., and Van Doorn P.A. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect. Immun. 70 (2002) 1202-1208
4. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
5. Bas S., Neff L., Vuillet M., Spenato U., Seya T., Matsumoto M., and Gabay C. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J. Immunol. 180 (2008) 1158-1168
6. Blaser M.J., Olivares A., Taylor D.N., Cornblath D.R., and McKhann G.M. Campylobacter serology in patients with Chinese paralytic syndrome. Lancet 338 (1991) 3080-3309
7. Carpentier P.A., Duncan D.S., and Miller S.D. Glial Toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav.Immun. 22 (2008) 140-147
8. Carpo M., Pedotti R., Allaria S., Lolli F., Matà S., Cavaletti G., Protti A., Pomati S., Scarlato G., and Nobile-Orazio E. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J. Neurol. Sci. 168 (1999) 75-77
9. Cheng C., Qin Y., Shao X., Wang H., Gao Y., Cheng M., and Shen A. Induction of TNF-alpha by LPS in Schwann cell is regulated by MAPK activation signals. Cell Mol. Neurobiol. 27 (2007) 909-921
10. Colomar A., Marty V., Médina C., Combe C., Parnet P., and Amédée T. Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse SCs require the stimulation of P2X7 receptors. J. Biol. Chem. 278 (2003) 30732-30740
11. Deiters U., Gumenscheimer M., Galanos C., and Mühlradt P.F. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses. Infect Immun. 71 (2003) 4456-4462
12. Dupin E., Real C., Glavieux-Pardanaud C., Vaigot P., Le N., and Douarin M. Reversal of developmental restrictions in neural crest lineages: transition from SCs to glial-melanocytic precursors in vitro. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5229-5233
13. Enzan H., Hiroi M., Saibara T., Onishi S., Yamamoto Y., Yamamoto H., and Hara H. Immunoelectron microscopic identification of asialo GMl-positive cells in adult rat liver. Virchows Archiv B Cell Pathol. 60 (1991) 389-398
14. Exley A.R., Smith N.S., and Winer J.B. Tumor necrosis factor-alpha and other cytokines in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 57 (1994) 1118-1120
15. Gillen C., Jander S., and Stoll G. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and Wallerian degeneration. J. Neurosci. Res. 51 (1998) 489-496
16. Gold R., Zielasek J., Kiefer R., Toyka K.V., and Hartung H.-P. Secretion of nitrite by SCs and its effect on T-cell activation in vitro. Cell. Immunol. 168 (1996) 69-77
17. Haastert K., Mauritz C., Chaturvedi S., and Grothe C. Human and rat adult Schwann cell cultures: fast and efficient enrichment and highly effective non-viral transfection protocol. Nat. Protocols 2 (2007) 99-104
18. Hafer-Macko C.E., Sheikh K.A., Li C.Y., Ho T.W., Cornblath D.R., McKhann G.M., Asbury A.K., and Griffin J.W. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39 (1996) 625-635
19. Hao H.-N., Zhao J., Lotoczky G., Grever W.E., and Lyman W.D. Induction of human beta-defensin-2 expression in human astrocytes by lipopolysaccharide and cytokines. J. Neurochem. 77 (2001) 1027-1035
20. Hao, H.-N., Zheng, B., Nasser, S., Ren, W., Latteier, M.J., Wooley, P.H., Morawa, L.G., in press. The roles of monocytic heat shock protein 60 and Toll-like receptors in the regional inflammation response to wear debris particles. Journal of Biomedical Materials Research: Part A (Electronic publication ahead of print).
21. Hartung H.P., Reiners K., Schmidt B., Stoll G., and Toyka K.V. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann. Neurol. 30 (1991) 48-53
22. Hartung H.P., Kieseier B.C., and Kiefer R. Progress in Guillain-Barre syndrome. Curr. Opin. Neurol. 14 (2001) 597-604
23. Heine H., Kirschning C.J., Lien E., Monks B.G., Rothe M., and Golenbock D.T. Cutting edge: cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162 (1999) 6971-6975
24. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
25. Hughes R., and Cornblath D. Guillain-Barré syndrome. Lancet 366 (2005) 1653-1666
26. Kirschning C.J., Wesche H., and Ayres T.M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188 (1998) 2091-20977
27. Kroenke M.A., Carlson T.J., Andjelkovic A.V., and Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205 (2008) 1535-1541
28. Le Douarin N.M., and Dupin E. Multipotentiality of the neural crest. Curr. Opin. Genet. Dev. 13 (2003) 529-536
29. Lee H., Jo E.K., Choi S.Y., Oh S.B., Park K., Kim J.S., and Lee S.J. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem. Biophys. Res. Commun. 350 (2006) 742-747
30. Lehmann H.C., Köhne A., Zu G., Hörste M., Dehmel T., Kiehl O., Hartung H.-P., Kastenbauer S., and Kieseier B.C. Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies. J. Neuropathol. Experiment. Neurol. 66 (2007) 305-312
31. Linker R.A., Kruse N., Israel S., Wei T., Seubert S., Hombach A., Holtmann B., Luhder F., Ransohoff R.M., Sendtner M., and Gold R. Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation. J. Immunol. 180 (2008) 2204-2213
32. Lisak R.P., Skundric D., Bealmear B., and Ragheb S. The role of cytokines in Schwann cell damage, protection, and repair. J. Infect. Dis. 176 (1997) 173-199
33. Lu M.O., Duan R.S., Quezada H.C., Chen Z.G., Mix E., Jin T., Yang X., Ljunggren H.G., and Zhu J. Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice. J. Neuroimmunol. 186 (2007) 19-26
34. Maimone D., Annunziata P., Simone I.L., Livrea P., and Guazzi G.C. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neuroimmunol. 47 (1993) 55-61
35. Matsuguchi T., Musikacharoen T., Ogawa T., and Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol. 165 (2000) 5767-5772
36. Medzhitov R., Preston-Hurlburt Jr. P., and Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
37. Michalek S.M., Moore R.N., McGhee J.R., Rosenstreich D.L., and Mergenhagen S.E. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J. Infect. Dis. 141 (1980) 55-63
38. Neumann H. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr. Opin. Neurol. 16 (2003) 267-273
39. O'Brien K., Fitzgerald D.C., Naiken K., Alugupalli K.R., Rostami A.M., and Gran B. Role of the innate immune system in autoimmune inflammatory demyelination. Curr. Med. Chem. 15 (2008) 1105-1115
40. Ogawa-Goto K., Funamoto N., Ohta Y., Abe T., and Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J. Neurochem. 59 (1992) 1844-1849
41. Oliveira R.B., Ochoa M.T., Sieling P.A., Rea T.H., Rambukkana A., Sarno E.N., and Modlin R.L. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect. Immun. 71 (2003) 1427-1433
42. Poltorak A., He X., Smirnova I., Liu M.-Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
43. Prendergast M.M., and Moran A.P. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J. Endotoxin Res. 6 (2000) 341-359
44. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., and Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189 (1999) 615-625
45. Redford E.J., Kapoor R., and Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120 (1997) 2149-2157
46. Rees J.H., Gregson N.A., and Hughes R.A.C. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38 (1995) 809-816
47. Schessl J., Koga M., Funakoshi K., Kirschner J., Muellges W., Weishaupt A., Gold R., and Korinthenberg R. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome. Arch. Dis. Child. 92 (2007) 48-52
48. Shamash S., Reichert F., and Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22 (2002) 3052-3060
49. Sharief M.K., McLean B., and Thompson E.J. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome. Ann. Neurol. 133 (1993) 591-596
50. Shen A., Yang J., Gu Y., Zhou D., Sun L., Qin Y., Chen J., Wang P., Xiao F., Zhang L., and Cheng C. Lipopolysaccharide-evoked activation of p38 and JNK leads to an increase in ICAM-1 expression in SCs of sciatic nerves. FEBS. J. 275 (2008) 4343-4353
51. Skoff A.M., Lisak R.P., Bealmear B., and Benjamins J.A. TNF-alpha and TGF-beta act synergistically to kill Schwann cells. J. Neurosci. Res. 53 (1998) 747-756
52. Wagner R., and Myers R.R. SCs produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 73 (1996) 625-629
53. White F.A., Bhangoo S.K., and Miller R.J. Chemokines: integrators of pain and inflammation. Nature Reviews Drug Discovery. 4 (2005) 834-844
54. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
55. Yamamoto N., Fukata Y., Fukata M., and Yanagisawa K. GM1-ganglioside-induced Aβ assembly on synaptic membranes of cultured neurons. Biochimica et Biophysica Acta. 1768 (2007) 1128-1137
56. Yuki N., and Koga M. Bacterial infections in Guillain-Barre and Fisher syndromes. Cur. Opin. Neurol. 19 (2006) 451-457
57. Zhang H., Peterson J.W., Nielsen W.D., and Klimpel G.R. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159 (1997) 4868-4871
58. Zhang Y., Porterm S., and Wekerlem H. SCs and myasthenia gravis: preferential uptake of soluble and membrane bound AchR by normal and immortalized Schwann cells, and immunogenic presentation to AchR-specific T line lymphocytes. Am. J. Pathol. 136 (1990) 111-122